Most recently, Dr Duddu held the position of general manager and vice president of worldwide drug delivery technologies of Cima Labs, a wholly owned subsidiary of Cephalon.
Prior to Cephalon, Dr Duddu has served as vice president of pharmaceutical development at Nektar Therapeutics, a drug delivery company based in San Carlos.
Dr Duddu said: “Taris has truly novel drug-device convergence product candidates in therapeutic areas with high unmet medical need, and I am excited to accept this opportunity to take Taris to the next stage of its development.”
Michael Cima, co-founder and consultant to the Taris Biomedical management team, said: “We are extremely pleased that Sarma Duddu has joined Taris as the CEO. Sarma is a accomplished drug developer with significant expertise in drug delivery and is ideally suited to lead the company as it develops its products for genitourinary indications.”